SPP1 and cancer: Our study, however, observed upregulation of SPP1 in senescent T cells and cancer cells from BM, characterizing the association of the ligand‐receptor axes of the SPP1 pathway with senescence, immunosuppression and angiogenesis in BM of NSCLC patients.